| Code: MTA14619 | Publication Date: Oct 2026 |
The following is a data-backed list of the leading Tardive Dyskinesia Treatment Companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. Tanabe Pharma, Luye Pharma Group currently lead the competitive landscape, alongside several other established players shaping the Global Tardive Dyskinesia Treatment Market.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Tardive Dyskinesia Treatment Market.
| Company Name | Tanabe Pharma Corporation |
|---|---|
| Established Year | 1678 |
| Headquarters | Osaka, Japan |
| Official Website | Click Here |
Tanabe Pharma, a subsidiary of Mitsubishi Chemical Group, develops specialty pharmaceuticals for central nervous system (CNS) disorders, autoimmune diseases, and neurodegenerative conditions globally.
| Company Name | Luye Pharma Group Ltd. |
|---|---|
| Established Year | 1994 |
| Headquarters | Yantai, Shandong, China |
| Official Website | Click Here |
Luye Pharma Group is an international pharmaceutical company focusing on central nervous system (CNS) disorders, oncology, and cardiovascular therapies, utilizing advanced drug delivery systems for long-acting injectable formulations.
| Company Name | Neurocrine Biosciences, Inc. |
|---|---|
| Established Year | 1992 |
| Headquarters | San Diego, California, United States |
| Official Website | Click Here |
Neurocrine Biosciences is a biopharmaceutical leader focused on neuroscience, renowned for developing valbenazine, a flagship selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for tardive dyskinesia.
| Company Name | SOM Biotech SL |
|---|---|
| Established Year | 2009 |
| Headquarters | Barcelona, Catalonia, Spain |
| Official Website | Click Here |
SOM Biotech is a clinical-stage biopharmaceutical company utilizing proprietary AI-based drug repurposing platforms to discover and develop treatments for orphan CNS diseases.
| Company Name | Acadia Pharmaceuticals Inc. |
|---|---|
| Established Year | 1993 |
| Headquarters | San Diego, California, United States |
| Official Website | Click Here |
Acadia Pharmaceuticals specializes in developing and commercializing innovative therapies for central nervous system disorders, including treatments for Parkinson's disease psychosis and Rett syndrome, alongside ongoing R&D in neuropsychiatry.
| Company Name | AbbVie Inc. |
|---|---|
| Established Year | 2013 |
| Headquarters | North Chicago, Illinois, United States |
| Official Website | Click Here |
AbbVie is a global research-based biopharmaceutical enterprise with a comprehensive neuroscience portfolio, offering therapies for Parkinson's diseases and movement conditions following its acquisition of Allergan.
| Company Name | Serina Therapeutics, Inc. |
|---|---|
| Established Year | 2006 |
| Headquarters | Huntsville, Alabama, United States |
| Official Website | Click Here |
Serina Therapeutics is a pharmaceutical development company advancing small-molecule therapeutics using its proprietary POZ polymer platform to target CNS conditions, including Parkinson's disease.
| Company Name | Teva Pharmaceutical Industries Ltd. |
|---|---|
| Established Year | 1901 |
| Headquarters | Tel Aviv, Israel |
| Official Website | Click Here |
Teva Pharmaceutical Industries is a global leader in generic and specialty pharmaceuticals, widely recognized for developing deutetrabenazine, a modified VMAT2 inhibitor approved for tardive dyskinesia and Huntington's chorea.
| Company Name | Medicure Inc. |
|---|---|
| Established Year | 1997 |
| Headquarters | Winnipeg, Manitoba, Canada |
| Official Website | Click Here |
Medicure is a specialty pharmaceutical company focused on the development, acquisition, and commercialization of cardiovascular and neurological therapeutic products for acute and chronic care markets.
| Company Name | Sun Pharmaceutical Industries Ltd. |
|---|---|
| Established Year | 1983 |
| Headquarters | Mumbai, Maharashtra, India |
| Official Website | Click Here |
Sun Pharma is India's largest pharmaceutical company and a major global generic manufacturer, producing a broad portfolio of central nervous system therapeutics, generic neurology medicines, and specialty formulations.
ISO 9001:2015 CERTIFIED
Quality Management System for market research & advisory services
Cert. No. 3050261008135Q